[Congressional Record Volume 171, Number 34 (Thursday, February 20, 2025)]
[Senate]
[Page S1299]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 1207. Mr. MERKLEY proposed an amendment to the concurrent 
resolution S. Con. Res. 7, setting forth the congressional budget for 
the United States Government for fiscal year 2025 and setting forth the 
appropriate budgetary levels for fiscal years 2026 through 2034; as 
follows:

       At the end of title III, add the following:

     SEC. 3___. DEFICIT-NEUTRAL RESERVE FUND RELATING TO REDUCING 
                   FEDERAL HEALTH PROGRAM SPENDING FOR 
                   PRESCRIPTION DRUGS.

       The Chairman of the Committee on the Budget of the Senate 
     may revise the allocations of a committee or committees, 
     aggregates, and other appropriate levels in this resolution, 
     and make adjustments to the pay-as-you-go ledger, for one or 
     more bills, joint resolutions, amendments, amendments between 
     the Houses, motions, or conference reports relating to 
     reducing health care costs, which may include legislation 
     enabling Americans to have a much improved opportunity to 
     purchase prescription drugs at, or near, the lower prices 
     manufacturers charge in other similarly developed nations, 
     requiring pharmaceutical manufacturers to report annually the 
     amount of taxpayer dollars used to benefit manufacturers' 
     research and development efforts, or enacting other 
     mechanisms to purchase prescription drugs at lower prices, by 
     the amounts provided in such legislation for those purposes, 
     provided that such legislation would not increase the deficit 
     over the period of the total of fiscal years 2025 through 
     2034.
                                 ______